The treatment of Cataracts & Stroke with vitamins

Cataracts and Stroke: Mitamins custom make quality formulas for the treatment of Cataracts & Stroke with vitamins. A Cataracts & Stroke formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Stroke

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    200
    mg
    333%
    Vitamin E
    300
    IU
    1000%
    Riboflavin
    75
    mg
    4412%
    Zinc
    10
    mg
    67%
    Selenium
    300
    mcg
    429%
    Potassium
    100
    mg
    3%
    Alpha Lipoic Acid
    150
    mg
    *
    CoQ-10
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Ginkgo Extract
    160
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    N-Acetyl L-Cysteine
    250
    mg
    *
    Ginger Extract
    300
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cataracts and Stroke Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Effective Test For Detection Of Colorectal Cancer Is Under-used
An under-used colon cancer screening test now available in the U.S. effectively detects colorectal cancer and may help to improve colon cancer screening rates, according to investigators at the Kaiser Permanente Division of Research. The study appears in the Journal of the National Cancer Institute (JNCI).
Vandetanib Increases Progression-Free Survival In Patients With Advanced Non Small Cell Lung Cancer - Phase II Study
Results published in the Journal of Clinical Oncology1 show that AstraZeneca's investigational once-daily oral anti-cancer drug vandetanib in combination with docetaxel, increased progression free survival (PFS) compared with docetaxel alone in a phase II study of 127 patients with pre-treated advanced Non-Small Cell Lung Cancer (NSCLC). The trial, study 6 demonstrated that adding vandetanib 100mg to standard docetaxel therapy improved median PFS to 18.7 weeks (HR=0.
This information concerning the support of Cataracts and Stroke treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments